What We Stand For

http://creatingsparks.com.gridhosted.co.uk/?endonezit=free-binary-options-trading-software-download WhatWeStandFor-1

http://gatehousegallery.co.uk/?myka=video-opzioni-binarie-24option&98d=ad This is the basic principal that Hope Cancer Care of Nevada is founded upon. From there, we have built our complete care facility into something truly special—something that puts our client’s comfort and health at the forefront.

source url We believe in caring for the entire individual, and not just focusing solely on the disease. We utilize the latest technologies, cutting-edge medical cancer treatments, healing powers of holistic medicine and personal care to confront your situation head on.

click WhatWeStandFor-2

http://unikeld.nu/?ioweo=opzioni-binarie-creare-account&c5a=f3 That is our creed when working with our patients. We believe that in order to best serve our patients, we must begin at the personal level. Establish a trust. Form a bond. And create a foundation in which we can build the optimum path to recovery —together.

http://www.hamburg-zeigt-kunst.de/?biudet=binary-options-no-deposit-bonus&c0f=2f We are committed to helping develop and sustain activities that promote cancer prevention and advanced research, so that future generations may one day live in a cancer-free world. Through this, we look to develop consultative relationships with referring physicians and institutions to help patients and survivors navigate through their unique medical, spiritual and support needs while living life to the fullest.

slide_0

Szent-Györgyi Prize to honor NCI’s Douglas R. Lowy and John T. Schiller

02/15/18

Dr. Douglas R. Lowy and Dr. John T. Schiller of the National Cancer Institute will receive the 2018 Szent-Gyorgyi Prize for Progress in Cancer Research for the development of HPV vaccines. …read more Source:: Cancer


Highly Processed Foods & Cancer Risk

02/15/18

By David Sampson A study out Wednesday suggests eating a lot of highly processed foods might be associated with higher rates of cancer. The study appears in BMJ, and the authors admit more study is needed, but warn that the … Read More


Rodents and Radiation: What to Take Away from New Study Findings

02/02/18

By David Sampson Preliminary data was released today from two rodent studies by the National Toxicology Program (NTP), to explore potential links between cell phones and cancer. The studies have found high exposure to radiofrequency radiation (RFR) resulted in tumors … Read More


Detecting cancer with a blood test: New study shows promise, but caution remains

01/19/18

By David Sampson A study published this week in Science reports promising results of a blood test designed to detect eight common cancer types by measuring circulating proteins and mutations in cell-free DNA. The study comes from the Johns Hopkins … Read More


Study links inflammation-causing foods to higher risk of colorectal cancer

01/18/18

By David Sampson A study in today’s JAMA Oncology links diets that include foods that can cause inflammation to an increased risk of colorectal cancer. Those foods include meats, refined grains, and high-calorie beverages. We asked Marji McCullough, SCD, RD, … Read More


Norman Sharpless sworn in as director of the National Cancer Institute

10/18/17

Norman E. “Ned” Sharpless, M.D., becomes the 15th director of the National Cancer Institute (NCI). He comes to NCI from the University of North Carolina School of Medicine, where he was director of the Lineberger Comprehensive Cancer Center. …read more … Read More


Behind the numbers: cancers associated with obesity

10/03/17

By David Sampson A report out today had a lot of us scratching our heads, when it said that about 630,000 people in the U.S. were diagnosed with a cancer associated with overweight and obesity in 2014. That sounds awfully … Read More


NCI-funded TMIST study compares 2-D and 3-D mammography for finding breast cancers

09/26/17

TMIST, the first randomized trial comparing two types of digital mammography for breast cancer screening, is enrolling participants. Developed by ECOG-ACRIN and NCI, the trial is comparing 2-D and 3-D mammography for finding breast cancers. …read more Source:: Cancer


NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award

09/06/17

Dr. Douglas R. Lowy and Dr. John T. Schiller of the National Cancer Institute receive the 2017 Lasker-DeBakey Clinical Medical Research Award for their significant research leading to the development of HPV vaccines. …read more Source:: Cancer


New Analysis Confirms Suspected Bias of Large U.S. Prostate Screening Study

09/05/17

By David Sampson A new paper appearing in Annals of Internal Medicine used simulation modeling to try to correct for a known bias in a notable U.S. trial of prostate cancer screening, called PLCO. That study along with a large … Read More